Otsuka Pharmaceutical co., Ltd.

11:30 AM - 11:45 AM, Wednesday, June 5, 2019 ・ Theater 1
Otsuka Pharmaceutical was established in 1964. At Otsuka Pharmaceutical, we are committed to a holistic approach to health and well-being of people and are striving to create innovative, thoroughly-original pharmaceutical and nutraceutical products based on our corporate philosophy “Otsuka-people creating new products for better health worldwide”. Analogous to riding on a bicycle, we drive on two wheels. We are looking for innovative licensing opportunities for indications with significant unmet need in CNS and renal diseases, to supplement our internal development pipeline and product portfolio. We are looking for clinical stage compounds, but will consider late preclinical if the science is compelling. We are also interested in the robust IND generation platform with new modalities other than small molecules.
Ticker:
OTSUKA
Exchange:
Tokyo
Company Type:
Company Website:
Company HQ State:
Not Provided.
Company HQ Country:
Japan
Year Founded:
Not Provided.
Main Therapeutic Focus:
Lead Product in Development:
Rexulti
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided.
Speaker
photo
Director
Otsuka Pharmaceutical